Maze Therapeutics Statistics
Total Valuation
MAZE has a market cap or net worth of $438.41 million. The enterprise value is $169.86 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MAZE has 43.80 million shares outstanding. The number of shares has increased by 303.36% in one year.
| Current Share Class | 43.80M |
| Shares Outstanding | 43.80M |
| Shares Change (YoY) | +303.36% |
| Shares Change (QoQ) | +1,077.27% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 33.02% |
| Float | 16.93M |
Valuation Ratios
The trailing PE ratio is 29.84.
| PE Ratio | 29.84 |
| Forward PE | n/a |
| PS Ratio | 0.54 |
| Forward PS | 137.52 |
| PB Ratio | 1.50 |
| P/TBV Ratio | 1.50 |
| P/FCF Ratio | 6.38 |
| P/OCF Ratio | 6.27 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 3.19, with an EV/FCF ratio of 2.47.
| EV / Earnings | 54.56 |
| EV / Sales | 1.01 |
| EV / EBITDA | 3.19 |
| EV / EBIT | 3.38 |
| EV / FCF | 2.47 |
Financial Position
The company has a current ratio of 16.10, with a Debt / Equity ratio of 0.09.
| Current Ratio | 16.10 |
| Quick Ratio | 15.81 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.44 |
| Debt / FCF | 0.38 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 34.38% and return on invested capital (ROIC) is 16.62%.
| Return on Equity (ROE) | 34.38% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 16.62% |
| Return on Capital Employed (ROCE) | 15.98% |
| Revenue Per Employee | $1.34M |
| Profits Per Employee | $24,904 |
| Employee Count | 125 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MAZE has paid $1.17 million in taxes.
| Income Tax | 1.17M |
| Effective Tax Rate | 2.21% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 9.74 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.27 |
| Average Volume (20 Days) | 104,079 |
Short Selling Information
The latest short interest is 2.03 million, so 4.63% of the outstanding shares have been sold short.
| Short Interest | 2.03M |
| Short Previous Month | 2.18M |
| Short % of Shares Out | 4.63% |
| Short % of Float | 11.98% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MAZE had revenue of $167.50 million and earned $3.11 million in profits. Earnings per share was $0.34.
| Revenue | 167.50M |
| Gross Profit | 167.50M |
| Operating Income | 50.20M |
| Pretax Income | -16.82M |
| Net Income | 3.11M |
| EBITDA | 53.23M |
| EBIT | 50.20M |
| Earnings Per Share (EPS) | $0.34 |
Full Income StatementBalance Sheet
The company has $294.37 million in cash and $25.82 million in debt, giving a net cash position of $268.55 million or $6.13 per share.
| Cash & Cash Equivalents | 294.37M |
| Total Debt | 25.82M |
| Net Cash | 268.55M |
| Net Cash Per Share | $6.13 |
| Equity (Book Value) | 292.07M |
| Book Value Per Share | 6.67 |
| Working Capital | 281.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $69.88 million and capital expenditures -$1.17 million, giving a free cash flow of $68.71 million.
| Operating Cash Flow | 69.88M |
| Capital Expenditures | -1.17M |
| Free Cash Flow | 68.71M |
| FCF Per Share | $1.57 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 29.97% and 31.01%.
| Gross Margin | 100.00% |
| Operating Margin | 29.97% |
| Pretax Margin | 31.71% |
| Profit Margin | 31.01% |
| EBITDA Margin | 31.78% |
| EBIT Margin | 29.97% |
| FCF Margin | 41.02% |
Dividends & Yields
MAZE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -303.36% |
| Shareholder Yield | -303.36% |
| Earnings Yield | 0.71% |
| FCF Yield | 15.67% |
Analyst Forecast
The average price target for MAZE is $25.67, which is 156.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.67 |
| Price Target Difference | 156.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MAZE has an Altman Z-Score of 8.12 and a Piotroski F-Score of 3.
| Altman Z-Score | 8.12 |
| Piotroski F-Score | 3 |